Literature DB >> 18402773

CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells.

Yu Wang1, Ting Li, Xiaoyan Qiu, Xiaoning Mo, Yingmei Zhang, Quansheng Song, Dalong Ma, Wenling Han.   

Abstract

CMTM is a novel family of proteins linking chemokines and TM4SF. Several members of this family are highly expressed in testes and regulate androgen receptor (AR) transcription activity. One member of this family, CMTM3, has the highest expression level in testes and contains one leucine zipper and two LXXLL motifs. As assessed with the dual-luciferase reporter assay, overexpression of CMTM3 represses AR transactivation, while knocking down it can increase AR transactivation. Moreover, CMTM3 inhibits prostate-specific antigen (PSA) expression in LNCaP cells at both mRNA and protein levels with no obvious influence on AR expression. Taken together, CMTM3 may play some roles in the maturation and maintenance of the male reproduction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18402773     DOI: 10.1016/j.bbrc.2008.03.143

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.

Authors:  F Hu; W Yuan; X Wang; Z Sheng; Y Yuan; C Qin; C He; T Xu
Journal:  Clin Transl Oncol       Date:  2015-05-20       Impact factor: 3.405

2.  CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.

Authors:  Heyu Zhang; Jianyun Zhang; Xu Nan; Xuefen Li; Jiafei Qu; Yingying Hong; Lisha Sun; Yan Chen; Tiejun Li
Journal:  Tumour Biol       Date:  2015-05-07

3.  CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.

Authors:  J Xie; Y Yuan; Z Liu; Y Xiao; X Zhang; C Qin; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2013-08-02       Impact factor: 3.405

4.  CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.

Authors:  Y Xiao; Y Yuan; Y Zhang; J Li; Z Liu; X Zhang; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

5.  Integrated Analyses of Phenotype and Quantitative Proteome of CMTM4 Deficient Mice Reveal Its Association with Male Fertility.

Authors:  FuJun Liu; XueXia Liu; Xin Liu; Ting Li; Peng Zhu; ZhengYang Liu; Hui Xue; WenJuan Wang; XiuLan Yang; Juan Liu; WenLing Han
Journal:  Mol Cell Proteomics       Date:  2019-03-13       Impact factor: 5.911

6.  CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.

Authors:  Ting Li; Yingying Cheng; Pingzhang Wang; Wenyan Wang; Fengzhan Hu; Xiaoning Mo; Hongxia Lv; Tao Xu; Wenling Han
Journal:  J Exp Clin Cancer Res       Date:  2015-10-16

7.  Divergence of mammalian higher order chromatin structure is associated with developmental loci.

Authors:  Emily V Chambers; Wendy A Bickmore; Colin A Semple
Journal:  PLoS Comput Biol       Date:  2013-04-04       Impact factor: 4.475

8.  A systems approach to prion disease.

Authors:  Daehee Hwang; Inyoul Y Lee; Hyuntae Yoo; Nils Gehlenborg; Ji-Hoon Cho; Brianne Petritis; David Baxter; Rose Pitstick; Rebecca Young; Doug Spicer; Nathan D Price; John G Hohmann; Stephen J Dearmond; George A Carlson; Leroy E Hood
Journal:  Mol Syst Biol       Date:  2009-03-24       Impact factor: 11.429

9.  CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.

Authors:  Yu Su; Yi Lin; Lianhai Zhang; Baocai Liu; Wanqiong Yuan; Xiaoning Mo; Xiaohong Wang; Henan Li; Xiaofang Xing; Xiaojing Cheng; Bin Dong; Ying Hu; Hong Du; Yubing Zhu; Ning Ding; Jiyou Li; Weili Liu; Yongzhen Ma; Xiaoyan Qiu; Jiafu Ji; Wenling Han
Journal:  Cancer Sci       Date:  2013-11-28       Impact factor: 6.716

10.  CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.

Authors:  Zesong Li; Jun Xie; Jianting Wu; Wenjie Li; Liping Nie; Xiaojuan Sun; Aifa Tang; Xianxin Li; Ren Liu; Hongbing Mei; Feng Wang; Zhiping Wang; Yaoting Gui; Zhiming Cai
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.